Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GlaxoSmithKline Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 120.22B | 14.8x | 0.01 | PKR 392.75 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbott Laboratories Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 91.99B | 15x | 0.11 | PKR 955 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Haleon Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 86.06B | 15.4x | 0.06 | PKR 736.99 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGP | Karachi | Healthcare | Pharmaceuticals | PKR 52.67B | 16.4x | 0.18 | PKR 199.99 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.7% Upside | Upgrade to Pro+ | |
Highnoon Labs | Karachi | Healthcare | Pharmaceuticals | PKR 48.12B | 13.7x | 0.41 | PKR 920 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Searle Company | Karachi | Healthcare | Pharmaceuticals | PKR 46.27B | 22x | -0.3 | PKR 91.50 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.6% Upside | Upgrade to Pro+ | |
Hoechst Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 30.99B | 15.8x | 0.15 | PKR 3,211 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Citi Pharma | Karachi | Healthcare | Pharmaceuticals | PKR 19.76B | 23.8x | 7.81 | PKR 88.48 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macter International | Karachi | Healthcare | Pharmaceuticals | PKR 16.88B | PKR 405.32 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
BF Biosciences | Karachi | Healthcare | Pharmaceuticals | PKR 16.03B | 35.2x | -4.01 | PKR 183.40 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -24.7% Downside | Upgrade to Pro+ | |
Ferozsons Labs | Karachi | Healthcare | Pharmaceuticals | PKR 15.49B | 18.7x | 0.35 | PKR 387 | 8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Liven Pharma | Karachi | Healthcare | Pharmaceuticals | PKR 5.49B | 36x | 0.17 | PKR 59.71 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Otsuka Pakistan | Karachi | Healthcare | Pharmaceuticals | PKR 4.41B | 142.9x | -2.29 | PKR 400.65 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |